Kimberly A. Parker is a partner in the firm's Litigation/Controversy Department, and a member of the Investigations and Criminal Litigation Practice Group. She joined the firm in 1998. Ms. Parker's practice focuses on white-collar criminal matters, internal corporate investigations, and congressional investigations. Ms. Parker has significant experience in matters involving the Foreign Corrupt Practices Act (FCPA).
Practice
Ms. Parker represents clients in a range of criminal and enforcement matters and also provides compliance and governance advice. She has conducted internal investigations in the United States, Asia, Africa, Europe, and Latin America. She has represented companies and individuals in a variety of FCPA enforcement matters. She also regularly counsels clients facing difficult FCPA issues in a variety of business contexts, and assists clients in developing and implementing FCPA compliance programs and conducting FCPA training. She is a regular speaker at FCPA events.
Before joining the firm, Ms. Parker was a staff attorney fellow at the American Civil Liberties Union's Reproductive Freedom Project.
Recent Highlights
- Ms. Parker represented Armor Holdings, now a subsidiary of BAE Systems, Inc., in its July 2011 FCPA settlement with the DOJ and SEC relating to the actions of a former employee of the company who later went on to become the informant in the DOJ’s 22-defendant FCPA sting case.
- Ms. Parker represented oil driller Helmerich & Payne in its July 2009 settlement with the DOJ and the SEC of FCPA matters involving payments to customs officials in Argentina and Venezuela.
- Ms. Parker represented The Purdue Frederick Company in its May 2007 settlement of federal criminal charges related to its pain drug, OxyContin.
- Ms. Parker represented the Titan Corporation in its March 2005 settlement with the Department of Justice and the SEC regarding charges that it violated the FCPA in connection with payments to the President of the Republic of Benin.
- Ms. Parker has represented companies and individuals in numerous FCPA enforcement matters before the Department of Justice and Securities and Exchange Commission.
- Ms. Parker represented a global financial institution in several inquiries by the Senate Permanent Subcommittee on Investigations.
Honors and Awards
Publications
Ms. Parker is a co-author, with Roger Witten and Jay Holtmeier of the firm's New York office, of the leading treatise in the field, Complying with the Foreign Corrupt Practices Act (Matthew Bender, 7th ed. 2010).
She has also written the following articles:
- Anti-Bribery Considerations for Private Equity Firms and Investors, The Journal of Private Equity, Vol. 13, No. 4 (Fall 2010) (co-authored with Roger M. Witten, Jay Holtmeier, and Serena B. Wille).
- The Increased Prosecution of Individuals Under the FCPA: Trends and Implications, Bloomberg Law Reports -- Risk and Compliance, Vol. 2. No. 12 (2009) (co-authored with Roger M. Witten, Jay Holtmeier, and Lillian H. Potter).
- Complying with the United States Foreign Corrupt Practices Act, LexisNexis Insights & Analysis, Expert Commentaries (Dec. 22, 2009) (co-authored with Roger M. Witten and Jay Holtmeier).
- Prescriptions for Compliance with the Foreign Corrupt Practices Act: Identifying Bribery Risks and Implementing Anti-Bribery Controls in Pharmaceutical and Life Sciences Companies, The Business Lawyer, Vol. 64, No. 3 (May 2009) (co-authored with Roger M. Witten, Jay Holtmeier, and Thomas J. Koffer).
- The FCPA Internal Controls Provisions – A Sleeping Giant Awakes, PricewaterhouseCoopers 2005 Securities Litigation Study (2005) (co-authored with Roger M. Witten).
- Steering Clear of Bribery, European Counsel, Vol. V, No. 4 (May 2000) (co-authored with Roger M. Witten).